SP TRIO TABLET

Product Description

Product Name: SP TRIO TABLET
Composition: Sitagliptin 100mg + Dapagliflozin 10mg

Product Description for Trade India & B2B Platforms:

SP TRIO TABLET is an advanced dual-therapy formulation combining Sitagliptin 100mg and Dapagliflozin 10mg for the effective management of Type 2 Diabetes Mellitus. Designed to improve glycemic control through complementary mechanisms, this combination targets both insulin regulation and glucose excretion. Ideal for pharmaceutical wholesalers, retail chains, and bulk medicine suppliers, SP TRIO TABLET is a high-demand product in the modern antidiabetic therapy segment.

Key Benefits:

• Dual-Action Control:
  Sitagliptin (DPP-4 inhibitor): Enhances insulin secretion and reduces glucagon levels.
  Dapagliflozin (SGLT2 inhibitor): Promotes renal glucose excretion for better glycemic control.

• HbA1c Reduction: Proven efficacy in lowering long-term blood sugar levels.

• Weight-Neutral & Cardio-Renal Friendly: Supports weight control and offers added cardiovascular and kidney protection.

• Improved Patient Compliance: Single daily tablet simplifies therapy regimen.

Usage/Application:

• Indicated for adults with Type 2 Diabetes who require dual oral therapy.

• Prescribed when metformin alone or lifestyle changes do not provide adequate glycemic control.

• To be used under medical supervision, ideally alongside diet and exercise.

Why Choose SP TRIO TABLET:

• High-efficacy dual therapy in a convenient oral tablet.

• Manufactured in WHO-GMP certified facilities with strict quality standards.

• Available for bulk supply, custom branding, and private labeling.

• Excellent ROI for distributors and retailers in the diabetic care market.

For bulk orders, distributor pricing, or private label partnerships, contact us today.
SP TRIO TABLET Dual Strength, Double Benefit in Diabetes Management.